Barclays
ERAS icon

Barclays’s Erasca ERAS Stock Holding History

Barclays’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
127,843
+82,764
+184% +$1.18M ﹤0.01% 2251
2026
Q1 		$729K Sell
45,079
-357,717
-89% -$4.23M ﹤0.01% 2952
2025
Q4 		$1.5M Buy
402,796
+134,544
+50% +$378K ﹤0.01% 3138
2025
Q3 		$585K Sell
268,252
-55,228
-17% -$87.8K ﹤0.01% 3712
2025
Q2 		$411K Buy
323,480
+73,886
+30% +$98.9K ﹤0.01% 3873
2025
Q1 		$342K Sell
249,594
-128,170
-34% -$220K ﹤0.01% 3752
2024
Q4 		$948K Buy
377,764
+33,834
+10% +$92.8K ﹤0.01% 3411
2024
Q3 		$939K Buy
343,930
+296,657
+628% +$836K ﹤0.01% 3395
2024
Q2 		$112K Sell
47,273
-17,046
-27% -$36.8K ﹤0.01% 3853
2024
Q1 		$132K Sell
64,319
-69,369
-52% -$139K ﹤0.01% 4323
2023
Q4 		$285K Buy
133,688
+90,760
+211% +$191K ﹤0.01% 4252
2023
Q3 		$84.6K Buy
42,928
+5,281
+14% +$13.5K ﹤0.01% 3657
2023
Q2 		$104K Sell
37,647
-17,951
-32% -$51.1K ﹤0.01% 3543
2023
Q1 		$167K Sell
55,598
-104,163
-65% -$379K ﹤0.01% 3894
2022
Q4 		$689K Buy
159,761
+102,673
+180% +$696K ﹤0.01% 3083
2022
Q3 		$445K Buy
57,088
+51,094
+852% +$412K ﹤0.01% 2772
2022
Q2 		$33K Sell
5,994
-7,628
-56% -$49.9K ﹤0.01% 4203
2022
Q1 		$117K Buy
+13,622
New +$158K ﹤0.01% 3711

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Barclays's ERAS Position: Q2 2026 in Review

Barclays increased its Erasca (ERAS) stake by 184% in Q2 2026, buying an estimated $1.18M and bringing the position to 127,843 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Barclays first reported a position in ERAS in Q1 2022 and has held it in 18 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Barclays held 127,843 shares of Erasca worth $2.34M as of Q2 2026.
  • Barclays bought 82,764 Erasca shares in Q2 2026, an estimated $1.18M.
  • Erasca made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2251 holding.
  • Barclays first reported a position in Erasca in Q1 2022 and has held it in 18 quarters since.
  • 257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.